• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    More On SPHS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Sophiris Bio, Inc. (SPHS)

    -NasdaqGM
    0.55 Down 0.04(6.76%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.59
    Open:0.56
    Bid:0.32 x 300
    Ask:0.73 x 200
    1y Target Est:3.60
    Beta:3.09
    Next Earnings Date:N/A
    Day's Range:0.54 - 0.56
    52wk Range:0.42 - 3.73
    Volume:34,868
    Avg Vol (3m):398,215
    Market Cap:9.26M
    P/E (ttm):N/A
    EPS (ttm):-1.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SPHS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.02
    Quarterly EPS Est (Mar-15) :-0.36
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of products for the treatment of urological diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback